Mackenzie Financial Corp Buys 17,447 Shares of Amdocs Limited (NASDAQ:DOX)

Mackenzie Financial Corp increased its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 32.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 71,351 shares of the technology company's stock after purchasing an additional 17,447 shares during the period. Mackenzie Financial Corp owned about 0.06% of Amdocs worth $6,271,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Lecap Asset Management Ltd. acquired a new position in Amdocs in the 4th quarter worth approximately $264,000. Vaughan David Investments LLC IL boosted its stake in shares of Amdocs by 1.7% during the 4th quarter. Vaughan David Investments LLC IL now owns 376,817 shares of the technology company's stock valued at $33,118,000 after buying an additional 6,448 shares during the period. Signature Estate & Investment Advisors LLC boosted its stake in shares of Amdocs by 5.7% during the 4th quarter. Signature Estate & Investment Advisors LLC now owns 30,040 shares of the technology company's stock valued at $2,640,000 after buying an additional 1,610 shares during the period. Cerity Partners LLC acquired a new stake in shares of Amdocs during the 4th quarter valued at $393,000. Finally, GHP Investment Advisors Inc. boosted its stake in shares of Amdocs by 10.9% during the 4th quarter. GHP Investment Advisors Inc. now owns 89,991 shares of the technology company's stock valued at $7,909,000 after buying an additional 8,840 shares during the period. Institutional investors and hedge funds own 92.02% of the company's stock.

Analyst Upgrades and Downgrades

DOX has been the subject of a number of research reports. StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday, March 15th. Barclays lifted their price objective on shares of Amdocs from $105.00 to $115.00 and gave the company an "overweight" rating in a research note on Thursday, February 8th. Finally, Citigroup lifted their price objective on shares of Amdocs from $96.00 to $104.00 and gave the company a "buy" rating in a research note on Wednesday, January 17th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of "Buy" and an average target price of $108.60.

Amdocs Stock Performance

DOX traded up $1.02 during trading on Friday, hitting $86.13. The stock had a trading volume of 936,315 shares, compared to its average volume of 507,224. The firm has a market cap of $10.12 billion, a PE ratio of 18.44, a P/E/G ratio of 1.40 and a beta of 0.69. Amdocs Limited has a 12 month low of $78.38 and a 12 month high of $99.75. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.21. The company has a 50 day simple moving average of $90.03 and a 200-day simple moving average of $87.29.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The company had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter in the previous year, the firm posted $1.33 EPS. The business's revenue was up 5.0% compared to the same quarter last year. Analysts expect that Amdocs Limited will post 5.87 EPS for the current year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be issued a dividend of $0.479 per share. This is an increase from Amdocs's previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $1.92 annualized dividend and a dividend yield of 2.22%. Amdocs's payout ratio is presently 41.11%.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.